Reminder of Pending GSK Investor Class Action Lawsuit Lead

Investors who have shares in GSK are being reminded by Levi & Korsinsky about a class action lawsuit that is currently pending. The deadline for investors to join as a lead plaintiff in this lawsuit is April 7, 2025.

The class action lawsuit primarily concerns GSK’s alleged violations of federal securities laws. Investors who purchased or otherwise acquired GSK securities between July 25, 2019, and December 27, 2021, are being encouraged to participate in the lawsuit. The lawsuit alleges that GSK made misleading statements and failed to disclose important information regarding the safety and efficacy of its products, particularly its oncology products.

The lawsuit further asserts that GSK did not disclose the extent of the de-risking efforts being undertaken by the company in relation to these products. Additionally, the lawsuit claims that GSK did not disclose adverse effects and results from its pharmaceutical products in clinical trials, which would have impacted the company’s financial performance.

In December 2021, it was revealed that GSK would be holding an investor event in February 2022, which would provide an update on the company’s strategy, performance, and growth outlook. This event would also shed light on GSK’s plans to address its challenges and opportunities, particularly in its oncology segment.

Levi & Korsinsky is a national law firm that specializes in securities litigation and is experienced in representing investors in shareholder disputes. The firm is focused on ensuring that shareholders’ rights are protected and that they have a voice in seeking justice for alleged corporate wrongdoing. Levi & Korsinsky is encouraging GSK investors who are interested in participating in the class action lawsuit to contact them before the April 7, 2025, deadline to ensure that they are included in the action.

In conclusion, GSK investors are being reminded of the pending class action lawsuit by Levi & Korsinsky, which alleges violations of federal securities laws by GSK. Investors who purchased or acquired GSK securities between July 25, 2019, and December 27, 2021, are encouraged to join the lawsuit before the April 7, 2025, deadline. Levi & Korsinsky is ready to support investors in seeking justice for alleged corporate wrongdoing and ensuring that their rights are protected in this matter.